HomeNewsBusinessEconomyCOVID-19 impact | Chief privacy officers to manage remote working risks

COVID-19 impact | Chief privacy officers to manage remote working risks

Remote working has put the spotlight on challenges related to data privacy. Hence, individuals with prior experience in handling data and digital information privacy issues are now in demand.

May 01, 2020 / 10:05 IST
Story continues below Advertisement
Representational image (Max Pixel)
Representational image (Max Pixel)

An appliance manufacturing firm had not expected any data privacy issues amidst the lockdown, until an internal video meeting in which an intruder tried to steal confidential information on its vendors. The firm is now hunting for a chief privacy officer.

Amidst the COVID-19 outbreak, companies are finding data privacy and security to be the biggest challenge due to remote working.

Story continues below Advertisement

With privacy officers being a prevalent role in sectors like IT/ITeS and banking, financial services, these companies are now the poaching ground.

Also Read: Live updates on COVID-19 in India

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show